RecruitingNCT06741995

Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy

Studying Dilated cardiomyopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Enrollment
1000 enrolled
Eligibility
18-75 years · All sexes
Timeline
20242027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06741995 on ClinicalTrials.gov

Other trials for Dilated cardiomyopathy

Additional recruiting or active studies for the same condition.

See all trials for Dilated cardiomyopathy

← Back to all trials